A Transient Increase in Eosinophils is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T

Sipuleucel-T is an autologous cellular immunotherapy used to treat asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Traditional short-term indicators of clinical response commonly used with chemotherapy have not correlated with survival in patients treat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: McNeel, Douglas G., Gardner, Thomas A., Higano, Celestia S., Kantoff, Philip W., Small, Eric J., Wener, Mark H., Sims, Robert B., DeVries, Todd, Sheikh, Nadeem A., Dreicer, Robert
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185225/
https://ncbi.nlm.nih.gov/pubmed/25189164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0073
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia